InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle
InMode Ltd. Ordinary Shares | FinOracle

InMode Ltd. Ordinary Shares

Symbol: (NASDAQ:INMD)

InMode Ltd. is an innovative medical technology company specializing in minimally invasive surgical and aesthetic solutions. With a focus on advanced radiofrequency technology, InMode offers a wide range of products for various applications, including body contouring, facial rejuvenation, and women’s health. Their cutting-edge devices have gained popularity among both healthcare professionals and patients alike, positioning InMode as a leading player in the industry.

Latest News

Welcome Back!

Login to your account below

Create New Account!

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.

Home
Trends
Premium
Favorite
Account
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?